23 May 2013
Emerging clinical use of drug-eluting balloons in challenging atherosclerotic lesions
With an unrestricted educational grant from BIOTRONIK
Chairperson:
G. Richardt
Learning Objectives
- To understand the specific characteristics of the Lux technology and its potential benefits
- To assess clinical results of the Lux technology in coronary or peripheral lesions